ENTITY – Page 3

CDC Staff and Medical Organization Liaisons Barred from New ACIP Covid-19 Working Group

5 days ago talkbio0Tagged ACIP, Centers for Disease Control and Prevention (U.S.), COVID19 (disease), Jr., medical groups, Policy, Robert F. Kennedy, staff exclusion, Vaccines, Working Group

CDC; ACIP; Covid-19; working group; staff exclusion; medical groups barred; vaccine policy; Robert F. Kennedy Jr.

Hundreds of HHS Workers Accuse RFK Jr. of Destroying Public Health Trust After CDC Attack

5 days ago talkbio0Tagged CDC, Centers for Disease Control and Prevention (U.S.), federal workers, harassment, Health, HHS, Misinformation, Public Health Trust, RFK Jr., vaccine skepticism, Violence

RFK Jr.; Health and Human Services (HHS); CDC attack; public health trust; misinformation; vaccine skepticism; harassment; violence against federal workers

Who Is Making AI Work in Drug R&D in 2025?

5 days ago talkbio0Tagged Advice, Aortic Valve Insufficiency, Big Pharma, biopharma startups, Clinical Trials, Drug Development, Efficiency, Precision Medicine, United States Food and Drug Administration

AI drug discovery; Big Pharma; biopharma startups; clinical trials; FDA guidance; personalized medicine; drug development efficiency

Recent Advances: AI in Life Sciences—Reimagining Teams, Technology, and Partnerships

5 days ago talkbio0Tagged Aortic Valve Insufficiency, Biological Science Disciplines, Data Integration, Drug Discovery, Generative AI, language models, Precision Medicine, strategic partnerships, team transformation, technology innovation

AI in life sciences; generative AI; large language models; team transformation; technology innovation; strategic partnerships; drug discovery; personalized medicine; data integration

Appia Bio Shuts Down Before Reaching Clinical Trials Amid Biotech Funding Crunch

5 days ago talkbio0Tagged Appia Bio, biotech closures, Cell Therapy, Clinical Trials, Indonesian language, Kite Pharma partnership, Neoplasms

Appia Bio; cell therapy; biotech shutdown; funding challenges; clinical trials; Kite Pharma partnership; oncology; biotech closures; IND application

Funding Drought Puts Pressure on Cell Therapy Startups Like Appia Bio

5 days ago talkbio0Tagged ACUA, Appia Bio, CAR-iNKT cells, Cell Therapy, Droughts, financing characteristics, venture

Appia Bio; cell therapy; funding drought; biotech; venture capital; Series A financing; ACUA platform; CAR-iNKT cells

AbbVie Buys Gilgamesh’s Psychedelic Drug Bretisilocin for $1.2B

6 days ago talkbio0Tagged AbbVie, Acquisition, bretisilocin, Dosage Forms, Gilgamesh, GM-2505, Hallucinogens, mental health, Neuroscience discipline

AbbVie; Gilgamesh Pharmaceuticals; psychedelic drug; bretisilocin; GM-2505; major depressive disorder; acquisition; mental health; neuroscience; pharmaceutical deal

Regeneron Reports Phase 3 Success for Cemdisiran in Rare Disease Generalized Myasthenia Gravis

6 days ago talkbio0Tagged Alnylam, cemdisiran, Infrequent, Myasthenia Gravis, Generalized, Regeneron, regulatory submission, RNA drug, RNA, Small Interfering, United States

Regeneron; Phase 3 trial; cemdisiran; generalized myasthenia gravis; rare disease; RNA drug; siRNA; Alnylam Pharmaceuticals; U.S. regulatory submission